17 new drugs on phase III studies during fist half this year.
Published: 2001-09-17 07:00:00
Updated: 2001-09-17 07:00:00
It was reported that 36 new drugs were underway of clinical studies, of which 17 drugs entered into the phase III studies. 4 drugs belong to anti-cancer and orphan drugs that required only clinical phase II studies for a commercial release.
The KFDA information reported to the parliamentary in...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
